Objective
Congestive Heart failure (CHF) affects more than 15 million European citizens and 1 in 5 people are at risk of developing CHF in their lifetime. It is the leading cause of hospitalizations in patients over 65 years of age, about 1 in 3 patients admitted to hospital will die within one year. CHF accounts for 1-2% (30 Billion €) of healthcare spending in Europe each year. The growth in the numbers of patients developing CHF is driven by the increasing age profile of the EU population and by the growing number of people developing obesity.
Early death and rehospitalization can be reduced dramatically, when the progress of the heart disease is monitored continuously with a wireless pressure sensor, permanently implanted in the patient’s left heart ventricle or left atrium. The implant can provide physicians with detailed real-time information about the patient’s vital functions (intra-cardiac pressure, cardiac output and heart rate) around the clock. Based on those readings, the physician can proactively direct the patient to tweak the medication for stabilizing intra-cardiac pressure and provide early personalized treatments to avoid a crisis that would otherwise lead to hospitalization or even death. No mobile system is available, which allows to continuously and wirelessly monitor the patient’s vital functions during normal daily activities, e.g. (house-)work, sports or outdoor use or during sleep time.
With the strong backgrounds in medicine, medical technology, nano- and micro fabrication as well as engineering and business background of the consortium the first, ultra-small cardiac pressure sensor implant for mobile, continuous 24-7-readout is investigated to be marketed beginning in phase III. One key for success is the incorporation of novel and proven nano-granular materials, which will be fabricated using a proprietary 3D nanoprinting technique (Nano-3D-Sense™) allowing for outstanding performance in miniaturization, biocompatibility and energy efficiency.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine ophthalmology glaucoma
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences clinical medicine cardiology cardiovascular diseases
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing
See all projects funded under this programme -
H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
64283 DARMSTADT
Germany
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.